Rotavirus
Baseline Epidemiology Data May Further Vaccine Development
Published in Vaccine Weekly, May 16th, 2001
by N.R. Saltmarsh, staff medical writer - Researchers in Australia have established baseline epidemiological patterns for rotavirus outbreaks that will allow future charting of new strains and measurement of vaccine efficacy. The G serotypes, mainly G1 (67.8%), were identified in 81.9% of subjects G1 serotypes were predominant in all hospitals, followed intermittently by G2 and only sporadically by G3 and G4 strains ...
R.F. Bishop and colleagues studied patterns of infection in 4,634 children with rotavirus-associated diarrhea who were admitted to eight Australian hospitals from 1993-1996.
Among their findings:
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2001-05-16)
More Articles from Vaccine Weekly
- Dengue Virus
Five Vaccine Formulations Safe, Immunogenic In Humans - Helicobacter pylori
New Antigen May Figure Into Vaccine Development - Anthrax
Vaccine Effective Against Virulent Bacterial Strains In Rabbits, Macaques - Immunization
American Cancer Society Endorses Hepatitis B 'Catch-up' Immunization for Children - Multiple Sclerosis
CDR2 BV6S2/6S5 Peptide Vaccine Safe And Immunogenic - Pneumococcus
Reported Distributions Of S. pneumoniae Serotypes May Be Inaccurate - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
